Cargando…

Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress

BACKGROUND: The purpose of this study was to assess the efficacy of specific neuromodulation treatments performed with radio electric asymmetric conveyer (REAC) technology in the treatment of the symptomatic triad depression, anxiety, and stress by the use of a specific psychometric test such as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinaldi, Arianna, Rinaldi, Chiara, Coelho Pereira, José Alfredo, Lotti Margotti, Matteo, Bittencourt, Marina Nolli, Barcessat, Ana Rita Pinheiro, Fontani, Vania, Rinaldi, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387613/
https://www.ncbi.nlm.nih.gov/pubmed/30858704
http://dx.doi.org/10.2147/NDT.S195466
_version_ 1783397620159348736
author Rinaldi, Arianna
Rinaldi, Chiara
Coelho Pereira, José Alfredo
Lotti Margotti, Matteo
Bittencourt, Marina Nolli
Barcessat, Ana Rita Pinheiro
Fontani, Vania
Rinaldi, Salvatore
author_facet Rinaldi, Arianna
Rinaldi, Chiara
Coelho Pereira, José Alfredo
Lotti Margotti, Matteo
Bittencourt, Marina Nolli
Barcessat, Ana Rita Pinheiro
Fontani, Vania
Rinaldi, Salvatore
author_sort Rinaldi, Arianna
collection PubMed
description BACKGROUND: The purpose of this study was to assess the efficacy of specific neuromodulation treatments performed with radio electric asymmetric conveyer (REAC) technology in the treatment of the symptomatic triad depression, anxiety, and stress by the use of a specific psychometric test such as the Depression Anxiety Stress Scale-42 items (DASS-42) version, which assesses simultaneously the severity of expression of this triad. PATIENTS AND METHODS: The design of this study was planned to compare two populations that performed DASS-42 test twice within a similar period of time. The first population performed the first DASS test before the treatment and the second test about 3 months later, at the end of two specific REAC neuromodulation treatments, neuropostural optimization (NPO) and neuropsychophysical optimization (NPPO), that have previously shown an efficacy in the treatment of depression, anxiety and stress. The second population (untreated), used as the randomized control group, consisted of a similar group by gender and age, who performed the DASS-42 test in an online platform twice, with an interval of about 3 months between the first and second tests, similar to the interval between the two tests in the treated group. RESULTS: The comparison between the treated group and the control group points out the REAC treatment efficacy in improving the quality of life. At the second DASS-42 test, self-administered about 3 months after the treatments, treated patients were positioned on average values of much milder severity in all the three clusters, depression, anxiety, and stress, while in untreated patients there was no significant difference between the mean values of the first and second DASS tests. CONCLUSION: The results obtained in this study, evaluated with the DASS-42 test, confirm that REAC-NPO and REAC-NPPO neuromodulation treatments can be useful tools for the clinical treatment of depression, anxiety, and stress, as already proven by previous results evaluated with different psychometric tests.
format Online
Article
Text
id pubmed-6387613
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63876132019-03-11 Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress Rinaldi, Arianna Rinaldi, Chiara Coelho Pereira, José Alfredo Lotti Margotti, Matteo Bittencourt, Marina Nolli Barcessat, Ana Rita Pinheiro Fontani, Vania Rinaldi, Salvatore Neuropsychiatr Dis Treat Original Research BACKGROUND: The purpose of this study was to assess the efficacy of specific neuromodulation treatments performed with radio electric asymmetric conveyer (REAC) technology in the treatment of the symptomatic triad depression, anxiety, and stress by the use of a specific psychometric test such as the Depression Anxiety Stress Scale-42 items (DASS-42) version, which assesses simultaneously the severity of expression of this triad. PATIENTS AND METHODS: The design of this study was planned to compare two populations that performed DASS-42 test twice within a similar period of time. The first population performed the first DASS test before the treatment and the second test about 3 months later, at the end of two specific REAC neuromodulation treatments, neuropostural optimization (NPO) and neuropsychophysical optimization (NPPO), that have previously shown an efficacy in the treatment of depression, anxiety and stress. The second population (untreated), used as the randomized control group, consisted of a similar group by gender and age, who performed the DASS-42 test in an online platform twice, with an interval of about 3 months between the first and second tests, similar to the interval between the two tests in the treated group. RESULTS: The comparison between the treated group and the control group points out the REAC treatment efficacy in improving the quality of life. At the second DASS-42 test, self-administered about 3 months after the treatments, treated patients were positioned on average values of much milder severity in all the three clusters, depression, anxiety, and stress, while in untreated patients there was no significant difference between the mean values of the first and second DASS tests. CONCLUSION: The results obtained in this study, evaluated with the DASS-42 test, confirm that REAC-NPO and REAC-NPPO neuromodulation treatments can be useful tools for the clinical treatment of depression, anxiety, and stress, as already proven by previous results evaluated with different psychometric tests. Dove Medical Press 2019-02-13 /pmc/articles/PMC6387613/ /pubmed/30858704 http://dx.doi.org/10.2147/NDT.S195466 Text en © 2019 Rinaldi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Rinaldi, Arianna
Rinaldi, Chiara
Coelho Pereira, José Alfredo
Lotti Margotti, Matteo
Bittencourt, Marina Nolli
Barcessat, Ana Rita Pinheiro
Fontani, Vania
Rinaldi, Salvatore
Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress
title Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress
title_full Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress
title_fullStr Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress
title_full_unstemmed Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress
title_short Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress
title_sort radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387613/
https://www.ncbi.nlm.nih.gov/pubmed/30858704
http://dx.doi.org/10.2147/NDT.S195466
work_keys_str_mv AT rinaldiarianna radioelectricasymmetricconveyerneuromodulationindepressionanxietyandstress
AT rinaldichiara radioelectricasymmetricconveyerneuromodulationindepressionanxietyandstress
AT coelhopereirajosealfredo radioelectricasymmetricconveyerneuromodulationindepressionanxietyandstress
AT lottimargottimatteo radioelectricasymmetricconveyerneuromodulationindepressionanxietyandstress
AT bittencourtmarinanolli radioelectricasymmetricconveyerneuromodulationindepressionanxietyandstress
AT barcessatanaritapinheiro radioelectricasymmetricconveyerneuromodulationindepressionanxietyandstress
AT fontanivania radioelectricasymmetricconveyerneuromodulationindepressionanxietyandstress
AT rinaldisalvatore radioelectricasymmetricconveyerneuromodulationindepressionanxietyandstress